Dr Kenneth G Schmidt, MD | |
2435 Ne Cumulus Ave Ste A, Mcminnville, OR 97128-8862 | |
(503) 472-6161 | |
(503) 434-6290 |
Full Name | Dr Kenneth G Schmidt |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Location | 2435 Ne Cumulus Ave Ste A, Mcminnville, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356346092 | NPI | - | NPPES |
157206 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | MD14203 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kenneth G Schmidt, MD 2435 Ne Cumulus Ave Ste A, Mcminnville, OR 97128-8862 Ph: (503) 472-6161 | Dr Kenneth G Schmidt, MD 2435 Ne Cumulus Ave Ste A, Mcminnville, OR 97128-8862 Ph: (503) 472-6161 |
News Archive
The Legislature will meet in special session today to give Gov. Jan Brewer authority to seek a Medicaid waiver from the federal government, the first step to cutting health care for 280,000 Arizonans. Brewer and Republican lawmakers say the move is needed to balance the state budget and keep the rest of the state's Medicaid program intact.
Schizophrenia is a chronic illness that most often comes on in late adolescence or young adulthood and can devastate patients' lives. Many physicians and researchers believe that early intervention can increase the chances for recovery, reduce recurrences and even prevent the warning signs of psychosis from progressing to the actual disease.
Electronic nicotine delivery systems (ENDS), or e-cigarettes, debuted in China in 2003 and have since become available globally, particularly through the Internet. While they resemble traditional tobacco cigarettes, they produce fewer toxins in the vapor for the smoker. Still, these novel products have unknown long-term health and addiction consequences, are of varying nicotine content and delivery, and may appeal to nonusers and youth. ENDS have been banned by health authorities in Canada and Australia.
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
› Verified 5 days ago
Dr. James R Ullrich, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2340 Nw Nut Tree Ln, Mcminnville, OR 97128 Phone: 503-472-2909 | |
Dr. Kimya-anhcina Lan Nguyen, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Se Stratus Ave, Suite 304, Mcminnville, OR 97128 Phone: 503-434-6688 | |
Amy Susan Kalina, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Se Stratus Ave, Willamette Valley Hospitalists, Mcminnville, OR 97128 Phone: 503-435-6441 | |
Dr. Alan Wayne Hurty Ii, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Se Stratus Ave, Suite 303, Mcminnville, OR 97128 Phone: 503-472-0101 Fax: 503-472-6363 | |
Dr. Maria Angela Carpena Galang, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 375 Se Norton Ln, Suite A, Mcminnville, OR 97128 Phone: 503-472-9002 Fax: 503-474-0157 | |
John Scott Gibson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2375 Ne Cumulus Ave, Mcminnville, OR 97128 Phone: 503-472-0888 Fax: 503-434-7246 | |
Dr. Shweta Patel, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 232 Ne Norton Ln, Mcminnville, OR 97128 Phone: 503-434-1159 Fax: 503-434-1190 |